The guaC (GMP reductase), nadC (quinolinate phosphoribosyltransferase), and aroP (aromatic amino acid permease) genes of Escherichia coli K-12 were located in the 2.5-min region of the chromosome (mutT-guaCnadC-aroP-aceE) by a combination of linkage analysis, deletion mapping, restriction analysis, and plasmid subcloning. The guaC locus expressed a product of Mr 37,000 with a clockwise transcriptional polarity, arhd the GMP reductase activities of guaC+ plasmid-containing strains were amplified 15-to 20-fold.
verting guanine nucleotides to adenine nucleotides, GMP reductase plays a pivotal role in the intracellular interconversion and balance of adenine and guanine nucleotides (21, 22) . A simple lack of GMP reductase activity does not lead to purine auxotrophy, since the de novo biosynthesis of purine nucleotides via IMP remains intact. However, in purine auxotrophs blocked before the formation of IMP, a GMP reductase deficiency prevents the utilization of xanthine or guanine derivatives as purine sources. In Escherichia coli, GMP reductase is encoded by the guaC gene, which has been reported to lie clockwise of azi (19) and to be between the mutT and nadC loci (J. Gots, personal communication, cited in reference 1) at 2.5 min in the linkage map. The guaC gene is induced by GMP (10, 29) , and its expression is also regulated by cyclic AMP (2), by the intracellular ratio of adenine and guanine nucleotides (3), and by glutamine and related analogs (9, 15) . The GMP biosynthetic genes (guaBA) are located at 54 min in the E. coli linkage map and are regulated independently of guaC (24, 28) .
The nadC-aroP region of the E. coli chromosome encoding quinolinate phosphoribosyltransferase and the aromatic amino acid permease was originally isolated as a 10.5-kilobase (kb) HindIII fragment in a pBR322 derivative (pGS15) during studies on the adjacent pyruvate dehydrogenase complex genes, aceEF-lpd (11) (12) (13) . More recently, the guaC gene was subcloned from an RP4::Mu cointegrate carrying the leu-mutT-guaC region, and the guaC product was identified as a polypeptide of Mr 36,000 (26) . Here, we report (i) the genetic and physical localization of the guaC, nadC, and aroP genes by deletion mapping and subcloning studies; (ii) evidence for the transcriptional polarity of guaC (clockwise); (iii) confirmation of the subunit size of GMP reductase (Mr 37,000); and (iv) a 15-to 20-fold amplification of GMP reductase activity obtained with a guaC+ multicopy plasmid.
The bacterial strains, bacteriophages, and plasmids used are described in analysis of plasmids have been described elsewhere (12, 23, 25, 34) . Strain ED8641 was the primary transformation host for plasmid construction, and strain AB2480 was used in the maxicell procedure (30) . Strains were grown at 37°C in minimal medium (27) or rich medium (25) EcoRI (pGS84) and religation (Fig. 2) . In the case of pGS89, pGS15 was digested with BamHI and EcoRI (plus HindIII), followed by religation so that the 3.0-kb EcoRI-BamHI fragment (R1-Bl) was recloned between the corresponding sites in pBR322 with the complete elimination of tet promoter DNA (Fig. 2) . Other deletion derivatives were obtained from pGS85 with SphI (pGS135) or from pGS89 with BglII (pGS136) or SphI (pGS138 [18] ). The GuaC, NadC, AroP, and Ace phenotypes were tested nutritionally in purD212::TnS derivatives (Table 1) .
ing the 1.7-kb BgIII fragment (Bgg-Bg2) cloned with unknown polarity in the BamHI site of pBR322, was recovered from a ligation mixture containing BglII (plus EcoRI)-digested pGS89 and BamHI-digested pBR322 (Fig. 2) . Plasmid pGS139 was likewise constructed from mixed digests of pGS89 (SphI plus PstI) and pBR322 (SphI), so that the hybrid 2.2-kb SphI fragment (Sp,-Spvector) was recloned with an orientation defined by BamHI digestion. Finally, pGS140 was constructed by isolating the 2.7-kb BamHI-SphI fragment (B1-Sp2) from pGS85 and recloning it in pBR322. In every case, the ability to confer the Ampr phenotype was retained and the tet gene of the vector was inactivated, though three plasmids retained tet promoters acting on the bacterial inserts with a clockwise (pGS139 and pGS140) or undefined (pGS137) transcriptional polarity.
Ampr transformants of TX549 [A(guaC-aceE) purD::Tn5] containing each of the plasmids were tested for their GuaC, NadC, and AroP phenotypes, as well as Pur and Kan, to ensure that the purD212::Tn5 mutation was retained. The results indicated that the guaC gene is located in the 3.0-kb EcoRI-BamHI fragment (R1-Bl) of pGS89 and that it spans the SphI site (Sp1) because neither pGS138 nor pGS139 conferred the GuaC+ phenotype (Fig. 2) . The guaC locus also appeared to span one or both of the BglII sites (Bg1 or Bg2) because pGS137 was Gua- (Fig. 2) . This location is not entirely consistent with that proposed by Moffat and Mackinnon (26), since their restriction map of the guaC region is different. They located guaC within a 1.6-kb EcoRI-BgllISphI segment which is larger than the 0.9-kb R1-Bgj-Sp1 segment shown in Fig. 2 . In pGS138, the latter segment confers a GuaC-phenotype, indicating that the guaC locus extends beyond the SphI site. These discrepancies may be because Moffat and Mackinnon used a single clone derived from a partial Sau3A digest and a recombination-proficient strain (rather than a recombination-deficient or a deletion strain) for plasmid complementation (26) . The properties of other Ampr transformants showed that the nadC gene spans the other SphI site (Sp2), because pGS85 confers a NadC+ phenotype but pGS135 and pGS140 do not, and that the aroP gene resides within the 3.1-kb SphI-HindIII fragment (Sp2-H2) of pGS135 (Fig. 2) .
Expression of GMP reductase from multicopy plasmids. The expression of GMP reductase from the smallest guaC+ multicopy plasmid (pGS89) was tested in guaC+ and AguaC hosts under inducing and noninducing growth conditions ( a P-Lactamase activity was used to normalize GMP reductase activity due to copy number variation of plasmid pGS89 between growth conditions in strains TX582 and TX692. Strain TX582 had specific activities of 4.7 and 3.2, whereas strain TX692 had specific activities of 3.6 and 2.6 ,umol/min per mg of protein with noninducing and inducing conditions, respectively. IMP dehydrogenase activity was not normalized.
b Growth in minimal medium supplemented with 0.1% Casamino Acids and hypoxanthine (2, 3).
Growth in minimal medium supplemented with 0.1% Casamino Acids and guanosine (2, 3). (Fig. 3) . The Mr 37,000 polypeptide was identified as a product of the gua locus because it alone was expressed by the Gua+ plasinid (pGS89) but not by any of the Guaplasmids (pGS136 to pGS139) containing subfragments of the p0S89 itnsert (Fig. 2) and because it undoubtedly corresponded to the Mr 36,000 polypeptide previously correlated with guaC by TnS mutagenesis (26) .
Several lines of evidence indicated that the transcriptional polarity of the guaC locus is clockwise, i.e., left to right (Fig.   2 ). First, it was observed that pGS138 produced a unique polypeptide of Mr 28,500, which is probably a truncated guaC product, because no other polypeptides were detected with pGS89 or its subset of plasmids, pGS136 td pGS139 ( Fig. 2 and 3) . The simplest explanation that is consistent with the coding capacities of the plasmids is that expression of the guaC locus originates close to the EcoRI site (R1) and extends rightward across the entire BglII-SphI fragnment, Bg1-Sp1 (Fig. 2) (Fig. 2) . The orientation of the cassette in a putative gua-lacZY fusion (Lac' on complex medium with guanosine and X-Gal [5-bromo-4-chloro-3-indolyl-o-D-galactopyranoside]) confirmed that transcription is polarized rightward at the SstI site. It should also be noted that insertion of the cassette resulted in the inactivation of the GuaC+ phenotype of pGS89, and this inactivation is consistent with the location of the SstI site in the guaC locus. It also is highly probable that the Mr 37,000 polypeptide is identical to one of AMr 36,500 that was previously identified as the product of a gene of clockwise polarity in postinfection labeling studies with XG78N, as X nadC transducing phage (11) .
It was also concluded that the Mr 27,000 and 22,000 polypeptides originate from the leftmost 1.8-kb HindlIlEcoRI fragment (Hl-R1) and that the Mr 31,500 and 24,500 polypeptides derive from the rightmost 3.2-kb SphI-HindIII droP region (Sp2-H2), though neither corresponds to the aroP gene product (Mr 37,000), which is only expressed under inducing conditions (8) . The remaining polypeptides (Mr 41,000, 23,000, and 20,000) are encoded by the central region (containing B1 and Sp2) and probably include the product of the nadC gene, which spans the SphI site, SP2 (Fig. 2) .
The relative positions of the guaC, nadC, aroP, and ace genes have been deduced by genetic analysis in the 2.5-min region of the E. coli linkage map and further defined by molecular analysis of the corresponding 10.5-kb HindIII DNA fragment. A minimum of nine polypeptides were expressed from this fragment, and the identity of one (Mr 37,000), the guaC gene product (GMP reductase), was confirmed (26) . In addition, the guaC gene (ca. I kb in size) was located in the 10.5-kb DNA fragment as a region spanning the Bgl-Sp, segment, and its transcriptional polarity was deduced from the properties of a truncated guaC product and a guaC-lac fusion (Fig. 2) . The nadC gene appeared to span the SphI restriction site (Sp2), and the precise location of the aroP gene in the Sp2-H2 fragment has now been defined with pGS85 (8). The 10.5-kb fragment clearly contains several uiiidentified genes. One possibility is a guanine transport gene (guaP), which is reported to map in the mutT-nadC r*gion of Salmonella typhimurium (4). However, the existence of a distinct guaP locus has been questioned (7), and guanine transport is unaffected in two representative guaC deletion strains, A3 and AMO (7; K. Burton, personal coiimunication). The availability of a plasmid (pGS89) expressing high levels of GMP reductase should be very useful for further studies on the enzyme and for elucidating the complexities of the mechanism regulating its expression. 
